Wednesday 26 August 2020

This page is meant to provide a look at the schedule and events that will occur during WC11 on Wednesday 26 August 2020.

* the program is subject to change


  • Disease (D)
  • Ethics, Welfare and regulation (E)
  • Innovative technologies (IT)
  • Safety (S)

07h30-18h00 Registration and poster display

08h30-09h30 Keynote Lecture
Novel 3R technologies in early drug discovery – Dr. Jason Ekert, GSK

09h30-11h00 Platform sessions

  • (D) S118: A global movement to improve science using animal-free antibodies – A. Gray, AFABILITY / University of Nottingham, UK
  • (E) S102: Refinement of pain & stress assessment to enhance animal welfare in rodents – N.H. Franco, i3S, University of Porto
  • (IT) S177: Innovative approaches for CNS research – from brain organoids to new single cell culture methods – T. Hartung, Johns Hopkins University
  • (S) S222: Integrated Approach to Testing and Assessment of Chemicals: Occam’s razor for the integration of New Approach Methodologies into 21st Century Human Health Decision-Making – J. Lambert, U.S. Environmental Protection Agency
  • (IT) S181: Use of New approach methodologies –NAMs- to derive Point(s) of departure; opportunities and limitations – G. Ouedraogo, L’Oreal
  • (S) S237: Application of an in vitro testing battery for developmental neurotoxicity (DNT) assessment in a regulatory context – A. Bal-Price, European Commission Joint Research Centre (JRC)
  • (E) S195: Industry and public sector partnerships in education to foster the implementation of alternative methods – C. Pellevoisin, EPISKIN

11h00-11h30 Coffee break at the exhibition and poster area

11h30-13h00 Platform sessions

  • (D) S208: Application of new-approach methodologies to assess the safety of medical devices – S. Hoffmann, seh consulting + services
  • (E) S113: Wildlife research and the 3Rs principles – M. Zemanova, Centre for Compassionate Conservation, University of Technology Sydney & Animalfree Research, Switzerland
  • (IT) S67: Using the Sematic Web for Rapid Integration of Publicly Available Biological Information – H. Mortensen, US EPA
  • (S) S202: QIVIVE
  • (IT) S65: Diving into the scientific knowledge big data looking for alternatives – M. Straccia, FRESCI
  • (D) S121: 3R in vaccines batch release: Progress and future strategies – D. Lambrigts, GSK
  • (E) S176: Continuous training of Animal Welfare Body members – C. Kunne, Dutch AWB platform

13h00-14h30 Lunch break at the exhibition and poster area

14h30-16h30 Platform sessions

  • (D) S127: Implementing the 3Rs in Safety Assessment and Drug Development – D. W. Lee, Genentech
  • (E) S219: Rigor, Relevance and Reproducibility in (animal) research: when “Science’s 3Rs” come into play – N. Dudoignon, SANOFI R&D
    *This session is sponsored and organized by Sanofi-Aventis Groupe
  • (IT) S117: Personalized medicine through human organoid models – C. Mummery, LUMC
  • (S) S231: Building confidence in Next Generation Risk Assessment – C. Westmoreland, Unilever
  • (E) S230: The in3 project: An integrated interdisciplinary approach to animal-free nanomaterial and chemical safety assessment – P. Jennings, Vrije Universiteit Amsterdam
  • (S) S245: hands-on experience with the application of NAMs in intelligent testing strategies under regulatory programs – H. Ketelslegers, Concawe
    *This session is sponsored and organized by Concawe
  • (E) S135: Advancing Three Rs education and training under a European Parliament Pilot Project – S. Louhimies, European Commission

16h30-17h00 Coffee break at the exhibition and poster area

17h00-18h00 Keynote Lecture
Digital Twins for Personalized Healthcare, Dr. Ger Janssen, Philips Research

19h30 Congress dinner